Oxular

Operator of a retinal therapeutics company intended to offer retinal disease treatment. The company provides tissue-specific delivery of potent drug products to address multiple pathophysiological pathways of retinal diseases such as age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and cystoid macular edema, enabling patients to increase the cure's effectiveness, reduce its side effects and minimize the frequency of their retinal treatments.

Partnerships

 

  

  

 

  

  

 

  

  

Clients